Acorda Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·PEARL RIVER, NY

Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York.

CEO

Cohen Ron

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q1 2024	3/31/24	5/14/24	→
10-K/A	FY 2023	12/31/23	4/29/24	→
10-K	FY 2023	12/31/23	4/1/24	→
10-Q	Q3 2023	9/30/23	11/14/23	→
10-Q	Q2 2023	6/30/23	8/9/23	→
10-Q	Q1 2023	3/31/23	5/11/23	→
↓

Earnings Releases (8-K)

17 shown

Filed	Period
11/13/23	Q4 FY2023	→
8/8/23	Q3 FY2023	→
5/11/23	Q2 FY2023	→
3/9/23	Q1 FY2023	→
11/1/22	Q4 FY2022	→
8/4/22	Q3 FY2022	→
↓

News (8-K)

63 shown

Filed	Type	Description
8/9/24	Exec Change	Material Modification to Rights of Security Holders	→
7/23/24	Reg FD	Regulation FD Disclosure	→
7/11/24	Acquisition	Completion of Acquisition or Disposition of Assets	→
6/25/24	Reg FD	Regulation FD Disclosure	→
6/12/24	Other	Other Events	→
6/4/24	Other	Other Events	→
↓

Prospectuses & Registrations

39 shown

Filed	Form	Description
8/9/24	S-8 POS	S-8 POS	→
8/9/24	S-8 POS	S-8 POS	→
8/9/24	S-8 POS	S-8 POS	→
8/9/24	S-8 POS	S-8 POS	→
8/9/24	S-8 POS	S-8 POS	→
8/9/24	S-8 POS	S-8 POS	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

15-12G

Aug 13, 2024

0001193125-24-19937315-12G

—

10.8 KB

EFFECT

Aug 12, 2024

9999999995-24-002489

—

1.8 KB

EFFECT

Aug 12, 2024

9999999995-24-002488

—

1.8 KB

EFFECT

Aug 12, 2024

9999999995-24-002487

—

1.8 KB

EFFECT

Aug 12, 2024

9999999995-24-002486

—

1.8 KB

EFFECT

Aug 12, 2024

9999999995-24-002485

—

1.8 KB

S-8 POS

Aug 9, 2024

0000950170-24-094776S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094712S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094708S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094705S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094701S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094699S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094697S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094696S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094694S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094690S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094688S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094682S-8 POS

—

49.0 KB

S-8 POS

Aug 9, 2024

0000950170-24-094680S-8 POS

—

49.0 KB

POS AM

Aug 9, 2024

0000950170-24-094678POS AM

—

36.7 KB

S-8 POS

Aug 9, 2024

0000950170-24-094675S-8 POS

—

49.0 KB

POS AM

Aug 9, 2024

0000950170-24-094672POS AM

—

36.7 KB

S-8 POS

Aug 9, 2024

0000950170-24-094671S-8 POS

—

49.0 KB

POS AM

Aug 9, 2024

0000950170-24-094668POS AM

—

36.7 KB

POS AM

Aug 9, 2024

0000950170-24-094664POS AM

—

36.7 KB

25 filings shown

Filed	Form	Description
4/27/23	DEF 14A	DEF 14A	→
4/27/23	DEFA14A	DEFA14A	→
11/7/22	DEFA14A	DEFA14A	→
11/1/22	DEFA14A	DEFA14A	→
10/31/22	DEFA14A	DEFA14A	→
10/31/22	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
6/23/23	4	FORM 4 SUBMISSION	→
6/23/23	3	FORM 3 SUBMISSION	→
6/23/23	4	FORM 4 SUBMISSION	→
6/23/23	4	FORM 4 SUBMISSION	→
6/23/23	4	FORM 4 SUBMISSION	→
6/23/23	4	FORM 4 SUBMISSION	→
↓

Acorda Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
8/13/24	15-12G	15-12G	→
8/12/24	EFFECT	EFFECT	→
8/12/24	EFFECT	EFFECT	→
8/12/24	EFFECT	EFFECT	→
8/12/24	EFFECT	EFFECT	→
8/12/24	EFFECT	EFFECT	→
↓